ETFs Holding CLSN »    CLSN Historical Stock Prices »
CLSN News Video: Thu, Oct 4, 2018, 10:33 AM — Thursday 10/4 Insider Buying Report: CLSN, EQT

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Celsion is a development stage oncology drug company focused on developing a portfolio of cancer treatments, including directed chemotherapies, deoxyribonucleic acid (DNA)-mediated immunotherapy and ribonucleic acid based therapies. Co.'s main product candidate is ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, in a Phase III clinical trial for the treatment of primary liver cancer, and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer. Second in Co.'s pipeline is GEN-1, a DNA-mediated immunotherapy for the localized treatment of ovarian and brain cancers. Self directed investors in Celsion Corp will be interested in keeping up with all Celsion Corp news they can find, both CLSN news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on CLSN. At RediNews, we simplify this task by presenting both CLSN news releases originating from Celsion Corp itself, and CLSN news from a variety of media outlets. Visitors can browse this news online and through our CLSN RSS news feed.


CLSN News — Articles, Videos, & Press Releases

Puma Biotech (PBYI) Q1 Earnings Top, Nerlynx Disappoints
Friday, May 10, 2019, 8:00 AM — Zacks
IVERIC bio's (ISEE) Q1 Loss Narrows, Gene Therapy in Focus
Thursday, May 9, 2019, 1:03 PM — Zacks
Implied ITOT Analyst Target Price: $72
Wednesday, May 8, 2019, 8:08 AM — ETF Channel
Medicines Company (MDCO) Q1 Loss Narrows, Inclisiran in Focus
Friday, April 26, 2019, 9:11 AM — Zacks
AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales
Friday, April 26, 2019, 8:59 AM — Zacks
Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA
Wednesday, April 17, 2019, 6:14 AM — Zacks
ProQR Initiates Dosing in Phase II/III Eye Disorder Study
Tuesday, April 16, 2019, 5:26 PM — Zacks
Look Under The Hood: IWC Has 26% Upside
Thursday, February 28, 2019, 8:08 AM — ETF Channel
The Math Shows ITOT Can Go To $70
Wednesday, January 23, 2019, 7:24 AM — ETF Channel
Add Up The Parts: IWC Could Be Worth $126
Wednesday, October 24, 2018, 7:34 AM — ETF Channel
CLSN is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

HYH News

RediNews invites financial news content websites to integrate our XML content for web sites by integrating our RSS feeds found throughout our website wherever news and stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic content is ideal for any financial portal or web portal, from business content web sites to corporate portal intranets. Let RediNews be your content provider of free financial content for news, perfect for location on stock market chart pages by symbol, adding another element of dynamic stock market content to your financial portal. If your web page content already includes elements like SEC filings, screener pages, historical chart information, and other cobranded financial web content, then headlines from RediNews can supplement this dynamic financial content meaningfully.

CLSN News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.